SlideShare a Scribd company logo
1 of 57
Haemoptysis
Case 1 23 y /M/known to have pulmonary  TB diagnosed  6 years ago ,pt received full   with anti TB ,ONE year ago pt developed  productive cough with SOB sick medical advice outside Sudan ended  with segmenectomy of the lower part of the Lt upper lobe.       C/o       high grade fever                     Cough Hemoptysis(small amount)
 This pt is not breathless at rest ,The fingers are not clubbed ,there is no evidence of nicotine staining  ,The venous pressure is not elevated, There are no palpable LN, The trachea is slightly deviated to the Lt .On inspection of the chest ,there is Lt thoractomy scare with flattening of the Lt chest wall .The apex beat is displaced to the Lt.Chest expansion  is reduced on the Lt.There are coarse inspiratory crepitation  bilaterally with widespread  expiratory wheeze.
Diagnosis post TB Broncheictasis
Case 2 70 years/M/ x.smoker(30 cigarette/day for 20 year lifted 15  years ago) C/O       hemoptysis (sudden twice moderate in amount) This  a gentleman not breathless at rest  Examination was normal CXR     Rt lower zone MASS Diagnosis    Carcinoma of the  lung
  Case 3  21y/M   C/O         Cough               Massive hemoptysis This pt not breathless at rest emaciated very pale with a collection of red bright blood about 300cc beside him .The fingers are not clubbed ,there is no evidence of nicotine staining  ,The venous pressure is not elevated, There are no palpable LN.The trachea is central with impaired percussion note bilaterally .breath sounds are reduced bilaterally with crepitation over all the chest. CXR looks like TB ESR  140 HIV  positive Diagnosis  pulmonary TB+ HIV +ve
Case  4 80 year/M  Referred   from dentition  hospital  AS hemoptysis for workup   Old man  is  not breathless at rest ,The fingers are not clubbed ,there is no evidence of nicotine staining  ,The venous pressure is not elevated, There are no palpable LN,  There is ulcerated bleeding mass on the anterior tip of the tong. Chest normal CXR  normal Sputum –ve for AAFB Diagnosis    as pseudohaemoptsis
Haemoptysis is the coughing of blood originating from the respiratory tract below the level of the larynx. Haemoptysis should be differentiated from: Haematemesis - vomiting of blood from (GI) tract. Pseudohaemoptysis - where a cough reflex is stimulated by blood not derived from the lungs or bronchial tubes. This may be from the oral cavity or nasopharynx or following aspiration of haematemesis into the lungs.
Classifications of severity vary:
Massive haemoptysis has been arbitrarily defined as a loss of between 100-600 ml blood over 24 hours. It is a life-threatening medical emergency. This highly variable amount is based on the fact that the anatomic dead space in most adult is 100-200ml.
[object Object]
  The pulmonary and bronchial circulation                                                                                             ,[object Object]
[object Object],   1/     Chronic parenchyma  inflammation leading to erosion of bronchial and vascular walls ,enlargement and proliferation of bronchial vessels, and formation of anastamoses between bronchial and pulmonary circulation and formation of bronchiectasis or lung abscesses.                         2/       Various vascular alteration, such as aneurismal formation,vasculitis and embolism.            ,[object Object],[object Object]
Non-Bronchial Systemic Collateral Circulation:  Systemic arteries may cross the pleural space and neovascularize the lung in a number of disease processes associated with inflammation of the lung parenchyma and the pleura.
Etiology
According to source of bleeding:1 Trachea or bronchus:  Malignancy  Bronchogenic carcinoma Endobronchial metastatic tumor Kaposi's sarcoma Carcinoid tumour Bronchitis Bronchiectasis Broncholithiasis Airway trauma Foreign body
Lung parenchyma:  Lung abscess Pneumonia - bacterial (e.g.Staphylococcus aureus, Pseudomonas aeruginosa) or viral (e.g. influenza)* Tuberculosis (TB) Fungal infection and mycetoma Hydatid cysts Goodpasture's syndrome Pulmonary haemosiderosis Wegener's granulomatosis Lupus pneumonitis Lung contusion "Crack" lung
Vascular:  Arteriovenous malformation Aortic aneurysm Pulmonary embolism (PE) Mitral stenosis Other cause of pulmonary venous hypertension, e.g. left ventricular failure (LVF) Trauma Iatrogenic (e.g. chest drain malposition, secondary to pulmonary artery catheter manipulation)
Other:  Pulmonary endometriosis Congenital or acquired systemic coagulopathy, e.g. leukaemia Anticoagulant or thrombolytic agents Factitious haemoptysis
Infection :                                                     Tuberculosis  /                                                                Rupture of Rasmussen aneurysms, which represent small ectatic portions of pulmonary arteries traversing thick walled cavities of chronic tuberculosis.                                     Bronchial artery erosions from parenchymal/airway necrosis and tubeculous bronchiectasis.                                                                   Chronic cavitary disease predisposing to the formation of secondary infections, such as mycetomas.
Chronic Airway Inflammation :                                  Bronchiectasis ;                                            Hemoptysis occur in 25-50%, present as a single massive episode of hemorrhage, or intermittent blood streaking intermixed with purulent sputum. In this condition ,the bronchial arteries are hypertrophied and ecstatic ,and accompanied by enlarged sub mucosal anastigmatic plexi in the bronchial  walls.
Neoplastic Diseases                                                                Bronchogenic Carcinoma                                                Approximately 7-10% of pt with BC present with a history of blood-streaked sputum or expectoration of small clots. In a large retrospective analysis of 877 pt with lung cancer, massive, terminal hemoptysis was noted in 29(3%).This report and other studies have confirmed that those present with massive hemoptysis secondary to lung cancer typically have a centrally located cavitary sqamous cell carcinoma.
Epidemiology
Incidence Haemoptysis is common. In most cases, it is mild, self-limiting and related to transitory infection but it should be considered a serious sign due to the risk of underlying pathology.  In the past, tuberculosis was a major cause but in the UK today, the majority of cases of haemoptysis are due to acute upper and lower respiratory tract infections, with lung cancer a much smaller but significant cause.
. In another UK primary care study, haemoptysis had a 7.5% positive predictive value for lung cancer in men and 4.3% in women, rising to 17.1% in men aged between 75-84 years. Haemoptysis has been considered a useful clinical sign of pulmonary embolism.
Risk factors Male >female. Middle to older age (>40 years increases the risk of a malignant cause).
Presentation may find it hard to identify the origin of their bleeding. Haemoptysis or haematemesis?
      Haemoptysis                                                                                      Haematemesis No nausea or vomiting                                                 Nausea and vomiting Concurrent lung disease                                              Concurrent gastric or hepatic disease Sputum  is frothy                                                             Vomitus is rarely frothy Sputum has a liquid or clotted appearance                  Typical coffee ground appearance Haemoptysis is bright red or pink                                  Haematemesis is brown to black Alkaline pH                                                                        Acidic pH Mixed with macrophages and neutrophils                     Mixed with food particles
Symptoms Abrupt onset cough, fever with bloody and purulent sputum - suggestive of acute pneumonia or bronchitis. Chronic productive cough - suggestive of chronic bronchitis or bronchiectasis. Fevers, night sweats and weight loss - consider TB and other infections or malignancy. Anorexia, weight loss and changing cough - think of possible bronchogenic carcinoma. Dyspnoea, fatigue, orthopnea, paroxysmal nocturnal dyspnoea, frothy pink sputum - suggestive of congestive heart failure. Anxiety, dyspnoea and pleuritic chest pain - consider a PE
Always enquire about: Tobacco use. Travel history - consider potential exposure to histoplasmosis, coccidioidomycosis or schistosomiasis. Weight loss. Occupational history - particularly, exposure to asbestos, arsenic, chromium, nickel and ethers
Signs Record vital signs, including oxygen saturation levels. Fever, tachycardia, tachypnoea, weight loss and hypoxia are all relevant. Check for cachexia, cyanosis, pallor, ecchymoses, telangiectasia and lymphadenopathy.
Inspect the nasal cavity and oropharynx for:  Extrapulmonary causes (pseudohaemoptysis) Signs of vasculitis Saddle nose, and nasal perforation suggest Wegener's granulomatosis. Orofacial and mucous membrane telangiectasia are associated with Osler-Weber-Rendu syndrome. Perform a cardiovascular examination. Significant signs may include:  The diastolic murmur of mitral stenosis. Signs of LVF. Tachypnoea, tachycardia, fixed split S2, pleural rub, and unilateral leg pain or swelling may indicate thromboembolic disease.
Lung signs that may be found with haemoptysis include:  Fine inspiratory rales (alveolar blood). Inspiratory and expiratory rhonchi (associated with airway secretions and blood). Look for evidence of an exacerbations of chronic obstructive pulmonary disease or lower respiratory tract infection. Unilateral wheeze and distal consolidation raise the suspicion of endobronchial tumour. Unilateral wheeze or stridor may also indicate the presence of a foreign body. With apical dullness and cachexia, TB should be considered.
Digital clubbing can reflect chronic lung disease (lung cancer, bronchiectasis, lung abscess). Supraclavicular lymphadenopathy, cachexia, hoarse voice, Cushing's syndrome, hyper pigmentation, and Horner's syndrome are all associated with malignancy.
Investigations Dependent on the clinical setting but these may include: FBC, ESR, U&Es, coagulation studies, urinalysis, arterial blood gases, sputum cytology and culture, acid-fast bacillus (AFB) smear and culture, D-dimer testing, and HIV test.
Imaging - CXR +/- CT scan. About 30% of patients with haemoptysis have normal CXRs. Look for:1 Cavitations (e.g. TB, necrotising pneumonia). Segmental or lobar atelectasis (obstructions due to lung cancer, bronchial adenoma, foreign body). Left atrial enlargement, Kerley B lines (mitral stenosis). Thickened bronchial walls (bronchiectasis). Lymphadenopathy. Infiltrates
Fibreoptic bronchoscopy enables direct visualization and is required where there is a mass on CXR, there are risk factors for cancer despite normal CXR, or where diagnosis remains open, particularly in instances of recurrent haemoptysis.
Electrocardiogram (ECG) +/-echocardiogram (ECHO) - if a cardiac cause or PE is suspected.
Management Treatment is according to the underlying cause.
Minor haemoptysis Effort should be concentrated on determining the origin of the haemoptysis, providing specific treatment where available and excluding serious underlying pathology. Normal CXR, history consistent with bronchitis - oral antibiotic, advise smoking cessation and follow-up in a few weeks. Consider chest CT scan and bronchoscopy where:  Haemoptysis lasts longer than 2 weeks. There are recurrent episodes of haemoptysis. The volume of haemoptysis is >30 ml per day. The patient is a smoker and >40 years old. There is suspected bronchiectasis.
All smokers or ex-smokers aged >40 years with persistent haemoptysis should urgently be referred to a chest physician under the two-week wait rules.
Moderate haemoptysis Moderate haemoptysis (30-50 ml in the previous 24 hours) requires hospitalization for observation, due to increased risk of further heavy bleeding. Nurse in the semi-sitting position when awake and with abnormal lung down when lying in bed. Consider cough suppression with codeine but avoid over sedation. Await bronchoscopy - diagnostic yield is often highest when performed a few days after bleeding has stopped.
Major haemoptysis This is a medical emergency. However, there are few large, good-quality, controlled trials looking at best management to guide practice - particularly in the medical versus surgical dilemma.
Resuscitate according to 'ABC' principles.  Intubate where there are signs of acute respiratory failure. Selective intubation of the right or left main bronchus with a large single-lumen endotracheal tube. Maintain oxygenation saturations with high flow oxygen and suction.  Obtain IV access and give fluids/blood transfusion as appropriate.  Octreotide and other vasopressor drugs are sometimes used to control acute life-threatening bleeding.  Correct any clotting abnormalities.  The patient will require admission to intensive care.
Localization of the bleeding site via radiology and early bronchoscopy. CXR and even CT scanning may not bechoscopy remains controversial and tends to depend on local preference and expertise helpful (due to the presence of aspirated blood). The use of rigid or flexible fibreoptic born.
Specific therapies to control bleeding:  Bronchoscopic therapy:  Iced saline lavage. Topical agents, e.g. use of thrombin or fibrinogen-thrombin glue. Endobronchial balloon catheter tamponade. Laser photocoagulation.
Angiography and embolisation - bronchial artery embolisation is an important technique, developed from the care of patients with cystic fibrosis (CF), who were not candidates for surgery. It may be used as definitive treatment or a bridge to surgery. Major complications are now rare, the most feared being spinal cord infarction. Initial control of bleeding is achieved in over 90% of CF patients, although recurrent bleeding occurs in 22-46%.
Surgical resection:  Segmentectomy Lobectomy Pneumonectomy Under emergency conditions, surgery is difficult, has a high risk of septic complications and a significant mortality rate.
  Radiotherapy - may be used to treat aspergillomas and vascular tumours.
Palliative care Haemoptysis is the presenting complaint in 7-10% of lung cancers and about 20-30% patients with lung cancer will experience it over the course of their illness. In 3%, massive haemoptysis is the terminal event. Management of haemoptysis in the context of a malignant disease depends on the volume of blood loss, its cause and prognosis. Given the bleak prognosis of a massive haemoptysis, active resuscitation may not be desired or appropriate.
. Under these circumstances, the emphasis should be on the relief of pain and of fear in the patient and supporting witnesses and family: Nurse lying on the side of the tumour. Administer parenteral opioid and fast-acting benzodiazepine.
With more minor haemoptysis, additional palliative care measures may include: Oral haemostatics, e.g. tranexamic acid. Cough suppression. Anticoagulation (where PE). Antibiotics (where infection). Radiotherapy or laser treatment of the tumour site.
Prognosis Haemoptysis may be a mild, self-limiting symptom or may herald serious underlying disease. Massive haemoptysis can directly cause death and has a bad prognosis, worse in some groups such as those with an underlying cancer. Risk of recurrence is associated with haemoptysis lasting more than five days and with a concurrent lung cancer diagnosis.
 IV vasopressin (Argipressin) is occasionally useful - the paediatric dose is 0.3 units/kg (maximum 20 units) over 20 minutes followed by 0.3 units/kg/hour (maximum 1 unit/kg/hour) continued for 12 hours after bleeding has stopped and gradually withdrawn over 24-48 hours (maximum duration 72 hours).  It can lead to water intoxication and can cause bronchoconstriction. IV terlipressin (for children >12 years) has fewer side effects; dose is 2mg then 1-2mg every 4-6 hours until bleeding is controlled, (maximum duration 72 hours); this is used by the adult unit.
Oral tranexamic acid has been used long term in recurrent bleeders with some success. Dose is 15-25 mg/kg tds (max 1.5 g/dose).
                  THANK YOU
Hemoptysis

More Related Content

What's hot (20)

Massive hemoptysis / Nahid Sherbini
Massive hemoptysis / Nahid SherbiniMassive hemoptysis / Nahid Sherbini
Massive hemoptysis / Nahid Sherbini
 
Hemoptysis
HemoptysisHemoptysis
Hemoptysis
 
Hemoptysis , definition, classification, causes and management
Hemoptysis , definition, classification, causes and managementHemoptysis , definition, classification, causes and management
Hemoptysis , definition, classification, causes and management
 
HEMOPTYSIS
 HEMOPTYSIS HEMOPTYSIS
HEMOPTYSIS
 
Massive hemoptysis
Massive hemoptysisMassive hemoptysis
Massive hemoptysis
 
Hemoptysis jack
Hemoptysis jackHemoptysis jack
Hemoptysis jack
 
Hemoptysis
Hemoptysis Hemoptysis
Hemoptysis
 
Hemoptysis case presentation
Hemoptysis case presentationHemoptysis case presentation
Hemoptysis case presentation
 
Causes of Haemoptysis
Causes of HaemoptysisCauses of Haemoptysis
Causes of Haemoptysis
 
Hemoptysise
HemoptysiseHemoptysise
Hemoptysise
 
Haemoptysis
HaemoptysisHaemoptysis
Haemoptysis
 
Hemoptysis and cough
Hemoptysis  and coughHemoptysis  and cough
Hemoptysis and cough
 
An Interesting Case Of Hemoptysis
An Interesting Case Of HemoptysisAn Interesting Case Of Hemoptysis
An Interesting Case Of Hemoptysis
 
Hemoptysis
HemoptysisHemoptysis
Hemoptysis
 
Hemoptysis and its management
Hemoptysis and its managementHemoptysis and its management
Hemoptysis and its management
 
Pulmonary hypertension
Pulmonary hypertensionPulmonary hypertension
Pulmonary hypertension
 
Pediatric pneumonia sadeghpour
Pediatric pneumonia  sadeghpourPediatric pneumonia  sadeghpour
Pediatric pneumonia sadeghpour
 
Hemoptysis, clinical picture & examination
Hemoptysis, clinical picture & examination Hemoptysis, clinical picture & examination
Hemoptysis, clinical picture & examination
 
PLEURAL TUBERCULOSIS, (PLEURAL EFFUSION)
PLEURAL TUBERCULOSIS, (PLEURAL EFFUSION)PLEURAL TUBERCULOSIS, (PLEURAL EFFUSION)
PLEURAL TUBERCULOSIS, (PLEURAL EFFUSION)
 
Alveolar hemorrhage
Alveolar hemorrhageAlveolar hemorrhage
Alveolar hemorrhage
 

Similar to Hemoptysis

Approach to patients with hemoptysis.pptx
Approach to patients with hemoptysis.pptxApproach to patients with hemoptysis.pptx
Approach to patients with hemoptysis.pptxamaliil
 
hemoptysispresentation.ppt
hemoptysispresentation.ppthemoptysispresentation.ppt
hemoptysispresentation.pptOpeyemi Muyiwa
 
Approach to patients with hemoptysis.pdf
Approach to patients with hemoptysis.pdfApproach to patients with hemoptysis.pdf
Approach to patients with hemoptysis.pdfamaliil
 
Approach to respiratory disorderv 3.pptx
Approach to respiratory disorderv 3.pptxApproach to respiratory disorderv 3.pptx
Approach to respiratory disorderv 3.pptxtesa10
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolismdrdoaagad
 
Cough And Hemoptsis
Cough And HemoptsisCough And Hemoptsis
Cough And Hemoptsishareesh c
 
zubairpulmoppt-190301145525.pdf
zubairpulmoppt-190301145525.pdfzubairpulmoppt-190301145525.pdf
zubairpulmoppt-190301145525.pdfEndreShitaye
 
Pulmonary embolism2006
Pulmonary embolism2006Pulmonary embolism2006
Pulmonary embolism2006mousa elshamly
 
haemoptysis.pptx
haemoptysis.pptxhaemoptysis.pptx
haemoptysis.pptxRuban Raj
 
hydrothorax presentation.pptx
hydrothorax presentation.pptxhydrothorax presentation.pptx
hydrothorax presentation.pptxAshraf Shaik
 
Respiratory lectures
Respiratory lecturesRespiratory lectures
Respiratory lecturesDOCTOR WHO
 
Pulmonary diseases of vascular origin(pulmonary embolism)
Pulmonary diseases of vascular origin(pulmonary embolism)Pulmonary diseases of vascular origin(pulmonary embolism)
Pulmonary diseases of vascular origin(pulmonary embolism)imrana tanvir
 
Pleural effusion icd niv
Pleural effusion icd niv  Pleural effusion icd niv
Pleural effusion icd niv prabuganesan3
 

Similar to Hemoptysis (20)

Hemoptysis
Hemoptysis Hemoptysis
Hemoptysis
 
Approach to patients with hemoptysis.pptx
Approach to patients with hemoptysis.pptxApproach to patients with hemoptysis.pptx
Approach to patients with hemoptysis.pptx
 
hemoptysispresentation.ppt
hemoptysispresentation.ppthemoptysispresentation.ppt
hemoptysispresentation.ppt
 
Approach to patients with hemoptysis.pdf
Approach to patients with hemoptysis.pdfApproach to patients with hemoptysis.pdf
Approach to patients with hemoptysis.pdf
 
Approach to respiratory disorderv 3.pptx
Approach to respiratory disorderv 3.pptxApproach to respiratory disorderv 3.pptx
Approach to respiratory disorderv 3.pptx
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolism
 
Cough And Hemoptsis
Cough And HemoptsisCough And Hemoptsis
Cough And Hemoptsis
 
Pleural effusion
Pleural effusionPleural effusion
Pleural effusion
 
zubairpulmoppt-190301145525.pdf
zubairpulmoppt-190301145525.pdfzubairpulmoppt-190301145525.pdf
zubairpulmoppt-190301145525.pdf
 
Bronchiectasis
BronchiectasisBronchiectasis
Bronchiectasis
 
Chronic PE
Chronic PEChronic PE
Chronic PE
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolism
 
Pulmonary embolism2006
Pulmonary embolism2006Pulmonary embolism2006
Pulmonary embolism2006
 
haemoptysis.pptx
haemoptysis.pptxhaemoptysis.pptx
haemoptysis.pptx
 
hydrothorax presentation.pptx
hydrothorax presentation.pptxhydrothorax presentation.pptx
hydrothorax presentation.pptx
 
Respiratory lectures
Respiratory lecturesRespiratory lectures
Respiratory lectures
 
Casos clinico-Radiológicos
Casos clinico-RadiológicosCasos clinico-Radiológicos
Casos clinico-Radiológicos
 
Approach to a case of pleural effusion
Approach to a case of pleural effusionApproach to a case of pleural effusion
Approach to a case of pleural effusion
 
Pulmonary diseases of vascular origin(pulmonary embolism)
Pulmonary diseases of vascular origin(pulmonary embolism)Pulmonary diseases of vascular origin(pulmonary embolism)
Pulmonary diseases of vascular origin(pulmonary embolism)
 
Pleural effusion icd niv
Pleural effusion icd niv  Pleural effusion icd niv
Pleural effusion icd niv
 

Recently uploaded

18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️9953056974 Low Rate Call Girls In Saket, Delhi NCR
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Celine George
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
Class 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfClass 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfakmcokerachita
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfUmakantAnnand
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsKarinaGenton
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxRoyAbrique
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxOH TEIK BIN
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 

Recently uploaded (20)

18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
Class 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfClass 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdf
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.Compdf
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its Characteristics
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
9953330565 Low Rate Call Girls In Rohini Delhi NCR
9953330565 Low Rate Call Girls In Rohini  Delhi NCR9953330565 Low Rate Call Girls In Rohini  Delhi NCR
9953330565 Low Rate Call Girls In Rohini Delhi NCR
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptx
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 

Hemoptysis

  • 2. Case 1 23 y /M/known to have pulmonary TB diagnosed 6 years ago ,pt received full with anti TB ,ONE year ago pt developed productive cough with SOB sick medical advice outside Sudan ended with segmenectomy of the lower part of the Lt upper lobe. C/o high grade fever Cough Hemoptysis(small amount)
  • 3. This pt is not breathless at rest ,The fingers are not clubbed ,there is no evidence of nicotine staining ,The venous pressure is not elevated, There are no palpable LN, The trachea is slightly deviated to the Lt .On inspection of the chest ,there is Lt thoractomy scare with flattening of the Lt chest wall .The apex beat is displaced to the Lt.Chest expansion is reduced on the Lt.There are coarse inspiratory crepitation bilaterally with widespread expiratory wheeze.
  • 4. Diagnosis post TB Broncheictasis
  • 5. Case 2 70 years/M/ x.smoker(30 cigarette/day for 20 year lifted 15 years ago) C/O hemoptysis (sudden twice moderate in amount) This a gentleman not breathless at rest Examination was normal CXR Rt lower zone MASS Diagnosis Carcinoma of the lung
  • 6.   Case 3 21y/M   C/O Cough Massive hemoptysis This pt not breathless at rest emaciated very pale with a collection of red bright blood about 300cc beside him .The fingers are not clubbed ,there is no evidence of nicotine staining ,The venous pressure is not elevated, There are no palpable LN.The trachea is central with impaired percussion note bilaterally .breath sounds are reduced bilaterally with crepitation over all the chest. CXR looks like TB ESR 140 HIV positive Diagnosis pulmonary TB+ HIV +ve
  • 7. Case 4 80 year/M Referred from dentition hospital AS hemoptysis for workup Old man is not breathless at rest ,The fingers are not clubbed ,there is no evidence of nicotine staining ,The venous pressure is not elevated, There are no palpable LN, There is ulcerated bleeding mass on the anterior tip of the tong. Chest normal CXR normal Sputum –ve for AAFB Diagnosis as pseudohaemoptsis
  • 8. Haemoptysis is the coughing of blood originating from the respiratory tract below the level of the larynx. Haemoptysis should be differentiated from: Haematemesis - vomiting of blood from (GI) tract. Pseudohaemoptysis - where a cough reflex is stimulated by blood not derived from the lungs or bronchial tubes. This may be from the oral cavity or nasopharynx or following aspiration of haematemesis into the lungs.
  • 10. Massive haemoptysis has been arbitrarily defined as a loss of between 100-600 ml blood over 24 hours. It is a life-threatening medical emergency. This highly variable amount is based on the fact that the anatomic dead space in most adult is 100-200ml.
  • 11.
  • 12.
  • 13.
  • 14. Non-Bronchial Systemic Collateral Circulation: Systemic arteries may cross the pleural space and neovascularize the lung in a number of disease processes associated with inflammation of the lung parenchyma and the pleura.
  • 16. According to source of bleeding:1 Trachea or bronchus: Malignancy Bronchogenic carcinoma Endobronchial metastatic tumor Kaposi's sarcoma Carcinoid tumour Bronchitis Bronchiectasis Broncholithiasis Airway trauma Foreign body
  • 17. Lung parenchyma: Lung abscess Pneumonia - bacterial (e.g.Staphylococcus aureus, Pseudomonas aeruginosa) or viral (e.g. influenza)* Tuberculosis (TB) Fungal infection and mycetoma Hydatid cysts Goodpasture's syndrome Pulmonary haemosiderosis Wegener's granulomatosis Lupus pneumonitis Lung contusion "Crack" lung
  • 18. Vascular: Arteriovenous malformation Aortic aneurysm Pulmonary embolism (PE) Mitral stenosis Other cause of pulmonary venous hypertension, e.g. left ventricular failure (LVF) Trauma Iatrogenic (e.g. chest drain malposition, secondary to pulmonary artery catheter manipulation)
  • 19. Other: Pulmonary endometriosis Congenital or acquired systemic coagulopathy, e.g. leukaemia Anticoagulant or thrombolytic agents Factitious haemoptysis
  • 20. Infection : Tuberculosis / Rupture of Rasmussen aneurysms, which represent small ectatic portions of pulmonary arteries traversing thick walled cavities of chronic tuberculosis. Bronchial artery erosions from parenchymal/airway necrosis and tubeculous bronchiectasis. Chronic cavitary disease predisposing to the formation of secondary infections, such as mycetomas.
  • 21. Chronic Airway Inflammation : Bronchiectasis ; Hemoptysis occur in 25-50%, present as a single massive episode of hemorrhage, or intermittent blood streaking intermixed with purulent sputum. In this condition ,the bronchial arteries are hypertrophied and ecstatic ,and accompanied by enlarged sub mucosal anastigmatic plexi in the bronchial walls.
  • 22. Neoplastic Diseases Bronchogenic Carcinoma Approximately 7-10% of pt with BC present with a history of blood-streaked sputum or expectoration of small clots. In a large retrospective analysis of 877 pt with lung cancer, massive, terminal hemoptysis was noted in 29(3%).This report and other studies have confirmed that those present with massive hemoptysis secondary to lung cancer typically have a centrally located cavitary sqamous cell carcinoma.
  • 24. Incidence Haemoptysis is common. In most cases, it is mild, self-limiting and related to transitory infection but it should be considered a serious sign due to the risk of underlying pathology. In the past, tuberculosis was a major cause but in the UK today, the majority of cases of haemoptysis are due to acute upper and lower respiratory tract infections, with lung cancer a much smaller but significant cause.
  • 25. . In another UK primary care study, haemoptysis had a 7.5% positive predictive value for lung cancer in men and 4.3% in women, rising to 17.1% in men aged between 75-84 years. Haemoptysis has been considered a useful clinical sign of pulmonary embolism.
  • 26. Risk factors Male >female. Middle to older age (>40 years increases the risk of a malignant cause).
  • 27. Presentation may find it hard to identify the origin of their bleeding. Haemoptysis or haematemesis?
  • 28. Haemoptysis Haematemesis No nausea or vomiting Nausea and vomiting Concurrent lung disease Concurrent gastric or hepatic disease Sputum is frothy Vomitus is rarely frothy Sputum has a liquid or clotted appearance Typical coffee ground appearance Haemoptysis is bright red or pink Haematemesis is brown to black Alkaline pH Acidic pH Mixed with macrophages and neutrophils Mixed with food particles
  • 29. Symptoms Abrupt onset cough, fever with bloody and purulent sputum - suggestive of acute pneumonia or bronchitis. Chronic productive cough - suggestive of chronic bronchitis or bronchiectasis. Fevers, night sweats and weight loss - consider TB and other infections or malignancy. Anorexia, weight loss and changing cough - think of possible bronchogenic carcinoma. Dyspnoea, fatigue, orthopnea, paroxysmal nocturnal dyspnoea, frothy pink sputum - suggestive of congestive heart failure. Anxiety, dyspnoea and pleuritic chest pain - consider a PE
  • 30. Always enquire about: Tobacco use. Travel history - consider potential exposure to histoplasmosis, coccidioidomycosis or schistosomiasis. Weight loss. Occupational history - particularly, exposure to asbestos, arsenic, chromium, nickel and ethers
  • 31. Signs Record vital signs, including oxygen saturation levels. Fever, tachycardia, tachypnoea, weight loss and hypoxia are all relevant. Check for cachexia, cyanosis, pallor, ecchymoses, telangiectasia and lymphadenopathy.
  • 32. Inspect the nasal cavity and oropharynx for: Extrapulmonary causes (pseudohaemoptysis) Signs of vasculitis Saddle nose, and nasal perforation suggest Wegener's granulomatosis. Orofacial and mucous membrane telangiectasia are associated with Osler-Weber-Rendu syndrome. Perform a cardiovascular examination. Significant signs may include: The diastolic murmur of mitral stenosis. Signs of LVF. Tachypnoea, tachycardia, fixed split S2, pleural rub, and unilateral leg pain or swelling may indicate thromboembolic disease.
  • 33. Lung signs that may be found with haemoptysis include: Fine inspiratory rales (alveolar blood). Inspiratory and expiratory rhonchi (associated with airway secretions and blood). Look for evidence of an exacerbations of chronic obstructive pulmonary disease or lower respiratory tract infection. Unilateral wheeze and distal consolidation raise the suspicion of endobronchial tumour. Unilateral wheeze or stridor may also indicate the presence of a foreign body. With apical dullness and cachexia, TB should be considered.
  • 34. Digital clubbing can reflect chronic lung disease (lung cancer, bronchiectasis, lung abscess). Supraclavicular lymphadenopathy, cachexia, hoarse voice, Cushing's syndrome, hyper pigmentation, and Horner's syndrome are all associated with malignancy.
  • 35. Investigations Dependent on the clinical setting but these may include: FBC, ESR, U&Es, coagulation studies, urinalysis, arterial blood gases, sputum cytology and culture, acid-fast bacillus (AFB) smear and culture, D-dimer testing, and HIV test.
  • 36. Imaging - CXR +/- CT scan. About 30% of patients with haemoptysis have normal CXRs. Look for:1 Cavitations (e.g. TB, necrotising pneumonia). Segmental or lobar atelectasis (obstructions due to lung cancer, bronchial adenoma, foreign body). Left atrial enlargement, Kerley B lines (mitral stenosis). Thickened bronchial walls (bronchiectasis). Lymphadenopathy. Infiltrates
  • 37. Fibreoptic bronchoscopy enables direct visualization and is required where there is a mass on CXR, there are risk factors for cancer despite normal CXR, or where diagnosis remains open, particularly in instances of recurrent haemoptysis.
  • 38. Electrocardiogram (ECG) +/-echocardiogram (ECHO) - if a cardiac cause or PE is suspected.
  • 39. Management Treatment is according to the underlying cause.
  • 40. Minor haemoptysis Effort should be concentrated on determining the origin of the haemoptysis, providing specific treatment where available and excluding serious underlying pathology. Normal CXR, history consistent with bronchitis - oral antibiotic, advise smoking cessation and follow-up in a few weeks. Consider chest CT scan and bronchoscopy where: Haemoptysis lasts longer than 2 weeks. There are recurrent episodes of haemoptysis. The volume of haemoptysis is >30 ml per day. The patient is a smoker and >40 years old. There is suspected bronchiectasis.
  • 41. All smokers or ex-smokers aged >40 years with persistent haemoptysis should urgently be referred to a chest physician under the two-week wait rules.
  • 42. Moderate haemoptysis Moderate haemoptysis (30-50 ml in the previous 24 hours) requires hospitalization for observation, due to increased risk of further heavy bleeding. Nurse in the semi-sitting position when awake and with abnormal lung down when lying in bed. Consider cough suppression with codeine but avoid over sedation. Await bronchoscopy - diagnostic yield is often highest when performed a few days after bleeding has stopped.
  • 43. Major haemoptysis This is a medical emergency. However, there are few large, good-quality, controlled trials looking at best management to guide practice - particularly in the medical versus surgical dilemma.
  • 44. Resuscitate according to 'ABC' principles. Intubate where there are signs of acute respiratory failure. Selective intubation of the right or left main bronchus with a large single-lumen endotracheal tube. Maintain oxygenation saturations with high flow oxygen and suction. Obtain IV access and give fluids/blood transfusion as appropriate. Octreotide and other vasopressor drugs are sometimes used to control acute life-threatening bleeding. Correct any clotting abnormalities. The patient will require admission to intensive care.
  • 45. Localization of the bleeding site via radiology and early bronchoscopy. CXR and even CT scanning may not bechoscopy remains controversial and tends to depend on local preference and expertise helpful (due to the presence of aspirated blood). The use of rigid or flexible fibreoptic born.
  • 46. Specific therapies to control bleeding: Bronchoscopic therapy: Iced saline lavage. Topical agents, e.g. use of thrombin or fibrinogen-thrombin glue. Endobronchial balloon catheter tamponade. Laser photocoagulation.
  • 47. Angiography and embolisation - bronchial artery embolisation is an important technique, developed from the care of patients with cystic fibrosis (CF), who were not candidates for surgery. It may be used as definitive treatment or a bridge to surgery. Major complications are now rare, the most feared being spinal cord infarction. Initial control of bleeding is achieved in over 90% of CF patients, although recurrent bleeding occurs in 22-46%.
  • 48. Surgical resection: Segmentectomy Lobectomy Pneumonectomy Under emergency conditions, surgery is difficult, has a high risk of septic complications and a significant mortality rate.
  • 49.   Radiotherapy - may be used to treat aspergillomas and vascular tumours.
  • 50. Palliative care Haemoptysis is the presenting complaint in 7-10% of lung cancers and about 20-30% patients with lung cancer will experience it over the course of their illness. In 3%, massive haemoptysis is the terminal event. Management of haemoptysis in the context of a malignant disease depends on the volume of blood loss, its cause and prognosis. Given the bleak prognosis of a massive haemoptysis, active resuscitation may not be desired or appropriate.
  • 51. . Under these circumstances, the emphasis should be on the relief of pain and of fear in the patient and supporting witnesses and family: Nurse lying on the side of the tumour. Administer parenteral opioid and fast-acting benzodiazepine.
  • 52. With more minor haemoptysis, additional palliative care measures may include: Oral haemostatics, e.g. tranexamic acid. Cough suppression. Anticoagulation (where PE). Antibiotics (where infection). Radiotherapy or laser treatment of the tumour site.
  • 53. Prognosis Haemoptysis may be a mild, self-limiting symptom or may herald serious underlying disease. Massive haemoptysis can directly cause death and has a bad prognosis, worse in some groups such as those with an underlying cancer. Risk of recurrence is associated with haemoptysis lasting more than five days and with a concurrent lung cancer diagnosis.
  • 54.  IV vasopressin (Argipressin) is occasionally useful - the paediatric dose is 0.3 units/kg (maximum 20 units) over 20 minutes followed by 0.3 units/kg/hour (maximum 1 unit/kg/hour) continued for 12 hours after bleeding has stopped and gradually withdrawn over 24-48 hours (maximum duration 72 hours).  It can lead to water intoxication and can cause bronchoconstriction. IV terlipressin (for children >12 years) has fewer side effects; dose is 2mg then 1-2mg every 4-6 hours until bleeding is controlled, (maximum duration 72 hours); this is used by the adult unit.
  • 55. Oral tranexamic acid has been used long term in recurrent bleeders with some success. Dose is 15-25 mg/kg tds (max 1.5 g/dose).
  • 56. THANK YOU